Piperazine

Piperazine

SCHEMBL28112864

C1CNCCN1.Cl.O=C(c1ccccc1)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
CTSD P07339 1/20 0.46
GAA P10253 2/20 0.46
HTT P42858 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
VCAM1 P19320 1/20 0.46
MAPK1 P28482 1/20 0.46
AKR1C3 P42330 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL28142889 0.98 ALDH1A1 (0.52) ALDH1A1NPC1RAB9ACTSDGAA
Piperidine SCHEMBL27656298 0.91 ALDH1A1 (0.49) ALDH1A1NPC1RAB9ACTSDGAA
SCHEMBL27637513 0.89 ALDH1A1 (0.59) ALDH1A1NPC1RAB9ACTSDGAA
SCHEMBL411359 0.89 ALDH1A1 (0.59) ALDH1A1NPC1RAB9ACTSDGAA
Hydrogen Sulfide SCHEMBL28794532 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ACTSDGAA
Water SCHEMBL4951772 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ACTSDGAA
Phosphine SCHEMBL28076950 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ACTSDGAA
SCHEMBL28783981 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ACTSDGAA
Methane SCHEMBL28075995 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ACTSDGAA
SCHEMBL28110765 0.87 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ACTSDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106103419-A Method for synthesizing vortioxetine through (2- (piperazine-1-yl) phenyl) aniline intermediate 斯洛文尼亚莱柯制药股份有限公司 2016-11-09 CN disclosed